Crossmark

Intravenous trimethoprim–sulfamethoxazole desensitization as a therapeutic strategy for late-onset Pneumocystis jirovecii pneumonia in a kidney transplant recipient: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-026-05849-8

Published Online: 2026-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yılmaz, Banu https://orcid.org/0000-0001-8736-9916
License Information

Text and Data Mining valid from 2026-01-30

Version of Record valid from 2026-02-24
More Information

Article History

Received: 20 October 2025

Accepted: 21 November 2025

First Online: 30 January 2026

Declarations

:

: Not applicable.

: Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The author declares that there are no competing interests.

Document is current

Any future updates will be listed below